| SpectraBase Spectrum ID |
1Nv7Y1bPu4k |
| Name |
3,4-PA N-(2-fluorobenzyl) |
| Classification |
Amphetamine designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
283.173627875 u |
| Formula |
C19H22FN |
| InChI |
InChI=1S/C19H22FN/c1-14(21-13-18-5-2-3-8-19(18)20)11-15-9-10-16-6-4-7-17(16)12-15/h2-3,5,8-10,12,14,21H,4,6-7,11,13H2,1H3 |
| InChIKey |
VTXILXMGJATWDE-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
283.390 g/mol |
| Nominal Mass |
283 u |
| Quality |
992 |
| Retention Index |
2138 |
| SMILES |
C=12C(=CC(CC(NCC=3C(=CC=CC3)F)C)=CC1)CCC2 |
| SPLASH |
splash10-0zfr-0900000000-874c2a4a04af01827234 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-(2-Fluorobenzyl)-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine
1-(2,3-Dihydro-1H-inden-5-yl)-N-(2-fluorobenzyl)propan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_020734 |
